We found that the serum level of GDF15 was significantly higher in CRC patients than in controls (745.78 ± 308.79 pg/ml in controls versus 1075.31 ± 481.35 pg/ml in CRC patients, P < 0.001). This evidence concerns the gene GDF15 and colorectal carcinoma.